Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company
GGenpact(G) Prnewswire·2024-07-29 20:05

Genpact's deep domain knowledge and data expertise enables embecta's vision to make a meaningful impact in the healthcare sector NEW YORK, July 29, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, has been working with embecta (Nasdaq: EMBC), a global diabetes care company, to support its spin-off from Becton Dickinson and Company (BD) and subsequent evolution as an independent leader in the diabetes technology market."Genpa ...